Population depletion activates autonomous CD154-dependent survival in biopsylike Burkitt lymphoma cells

Blood

Volumn 99, Issue 9, 2002, Pages 3411-3418

  Challa, Anita ^a,b,c,d,e   Eliopoulos, Aristides G ^a,b,c,d,e   Holder, Michelle J ^a,b,c,d,e   Burguete, Alondra Schweizer ^a,b,c,d,e   Pound, John D ^a,b,c,d,e   Chamba, Anita ^a,b,c,d,e   Grafton, Gillian ^a,b,c,d,e   Armitage, Richard J ^a,b,c,d,e   Gregory, Christopher D ^a,b,c,d,e   Martinez Valdez, Hector ^a,b,c,d,e   Young, Lawrence ^a,b,c,d,e   Gordon, John ^a,b,c,d,e  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d AMGEN INC   (United States)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 LIGAND;

ARTICLE; BURKITT LYMPHOMA; CELL COUNT; CELL POPULATION; CELL SURVIVAL; CONTROLLED STUDY; GENE EXPRESSION; GRAM NEGATIVE BACTERIUM; HUMAN; HUMAN CELL; LYMPHOMA CELL; PHENOTYPE; POPULATION DENSITY; PRIORITY JOURNAL; TUMOR BIOPSY;

EID: 0036566251     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.9.3411     Document Type: Article

References (61)

1. Conditioned and autonomous neoplasms: A review
2. Immunophenotypic characterization of follicle-center-cell-derived non-Hodgkin's lymphomas
3. Biology of the lymphomas: Cytogenetics, molecular biology, and virology
4. Current management of follicular lymphoma
5. Quantitative analysis of molecules which distinguish functional compartments within germinal centers
6. Germinal centers
7. Endemic Burkitt's lymphoma: Phenotypic analysis of tumour biopsy cells and of derived tumor cell lines
8. Isolation of a normal B cell subset with a Burkitt-like phenotype and transformation in vitro with Epstein-Barr virus
9. Malignant lymphoma in African children. II. Pathological entity
10. Histopathological definition of Burkitt's lymphoma
11. Cellular degeneration associated with characteristic nuclear fine structure changes in the cells from two cases of Burkitt's malignant lymphoma syndrome
12. Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis
13. CD77: An antigen of germinal center B cells entering apoptosis
14. Fortifying B cells with CD154: An engaging tale of many hues
15. Different Epstein-Barr virus B cell interactions in phenotypically distinct clones of a Burkiff's lymphoma cell line
16. Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells
17. Regulation of cell survival in Burkitt lymphoma: Implications from studies of apoptosis following cold-shock treatment
18. Mechanisms of antigen receptor-dependent apoptosis in human B lymphoma cell lines probed with a panel of 27 monoclonal antibodies
19. Transforming growth factor-β1 cooperates with anti-immunoglobulin for the induction of apoptosis in group I (biopsy-like) Burkitt lymphoma cell lines
20. Prevention of programmed cell death in Burkitt lymphoma cell lines by bcl-2-dependent and -independent mechanisms
21. Repression of apoptosis in human B-lymphoma cells by CD40-ligand and Bcl-2: Relationship to the cell-cycle and role of the retinoblastoma protein
22. Prolonged phenotypic, functional, and molecular change in group I Burkitt lymphoma cells on short-term exposure to CD40 ligand
23. Distinct role of follicular dendritic cells and T cells in the proliferation, differentiation, and apoptosis of a cen cantroblast cell line, L3055
24. Microenvironmental factors in the survival of human B lymphoma cells
25. Suppression of apoptosis in normal and neoplastic human B lymphocytes by CD40 ligand is independent of Bcl Bd-2 induction
26. Germinal center cells express bcl-2 protein after activation by signals which prevent their entry to apoptosis
27. The CD40 ligand expressed by human B cells costimulates B cell responses
28. Regulation of cytoplasmic, surface and soluble forms of CD40 ligand in mouse B cells
29. Regulation of CD40 and CD40 ligand by the AT-hook transcription factor AKNA
30. Ligation of CD40 influences the function of human Ig-secreting B cell hybridomas both positively and negatively
31. Bidirectional regulation of human B cell responses by CD40-CD40 ligand interactions
32. Incorporation of an isoleucine zipper motif enhances the activity of soluble CD40L
33. Minimal cross-linking and epitope requirements for CD40-dependent suppression of apoptosis contrast with those for the promotion of the cell cycle and homotypic adhesions in human B cells
34. Monoclonal antibody against a Burkitt lymphoma associated antigen
35. L spare group I Burkitt lymphoma cells from CD77-directed killing via Verotoxin-1 B chain but fail to protect against the holotoxin
36. CD40 induces apoptosis in carcinoma cells through activation of cytotoxic ligands of the tumor necrosis factor superfamily
37. L expression protects CD40-activated human B cells from Fas-mediated apoptosis
38. Bcl-x rather than Bcl-2 mediates CD40-dependent centrocyte survival in the germinal center
39. Bax is frequently compromised in Burkitt's lymphomas with irreversible resistance to Fas-induced apoptosis
40. CD40-mediated regulation of immune responses by TRAF-dependent and TRAF-independent signaling mechanisms
41. Regulation of CD27 expression in the course of germinal center B cell differentiation: The pivotal role of IL-10
42. Myc/Ig juxtaposition by chromosomal translocations: Some new insights, puzzles, and paradoxes
43. The pathogenesis of Burkitt's lymphoma
44. A c-myc antisense oligodeoxynucleotide inhibits entry into S-phase but not progress from G0 to G1
45. The role of c-myc in cell growth
46. Autocrine regulation of normal and malignant B lymphocytes
47. Apoptosis in Burkitt lymphoma cells is prevented by promotion of cysteine uptake
48. How bacteria talk to each other: Regulation of gene expression by quorum sensing
49. Expression, regulation, and function of B cell-expressed CD154 in germinal centers
50. + memory T cells contains preformed CD40 ligand that is rapidly but transiently expressed on their surface after activation through the T cell receptor complex
51. Fortifying B cells with CD154: An engaging tale of many hues
52. Soluble CD40 ligand induces selective proliferation of lymphoma cells in primary mantle cell lymphoma cell cultures
53. Inhibition of human B-cell lymphoma growth by CD40 stimulation
54. Antibodies to CD40 prevent Epstein-Barr virus-mediated human B-cell lymphomagenesis in severe combined immune deficient mice given human peripheral blood lymphocytes
55. Differential in vitro and in vivo antitumor effects mediated by anti-CD40 and anti-CD20 monoclonal antibodies against human B-cell lymphomas
56. Agonistic properties and in vivo antitumor activity of the anti-CD40 antibody SGN-14
57. Antibodies to murine CD40 stimulate normal B lymphocytes but inhibit proliferation of B lymphoma cells
58. T cell activation following infection of primary follicle center lymphoma B cells with adenovirus encoding CD154
59. CD40 antibody evokes a cytotoxic T-cell response that eradicates lymphoma and bypasses T-cell help
60. TNFR-associated factor family protein expression in normal tissues and lymphoid malignancies
61. Membrane-bound CD154, but not CD40-specific antibody, mediates NF-kappaB-independent IL-6 production in B cells